Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate vs Placebo for Pediatric Migraine Prophylaxis
NCT00237302Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jul 2001
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of topiramate in migraine, sponsored by Johnson & Johnson. Started Jul 2001; status: completed.
02
Drugs
topiramate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00237302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237302.